Afuco™ Anti-Human IL23A ADCC Therapeutic Antibody (BI 655066), ADCC Enhanced
Anti-IL23A ADCC Enhanced Antibody (BI 655066) is an ADCC enhanced antibody produced by our Afuco™ platform. BI 655066 is a fully human IgG1 mAb specific for the IL-23 p19 subunit. IL-23 is associated with plaque psoriasis susceptibility and pathogenesis. BI 655066 was well tolerated and associated with rapid, substantial, and durable clinical improvement in patients with moderate-to-severe psoriasis, supporting a central role for IL-23 in psoriasis pathogenesis.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-403CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | IL23A |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at -20°C. Avoid multiple freeze/thaw cycles. |